What’s in a Name? NAFLD Is Now MASLD Name change emphasizes the role of metabolic dysfunction in fatty liver disease.

After extensive discussion, AASLD, EASL & others have adopted a new naming system for fatty liver disease, intended to emphasize the underlying metabolic cause & reduce stigma by de-emphasizing alcohol & retiring "fatty". #TLM2023 #TLM23
www.hepmag.com/article/name...

Our poster ➡️Epidemiological and Clinical Characteristics of HBV and HDV Co-infected Patients Followed by the 🇨🇦 HBV Network #TLM2023

43.7% (69/158) had cirrhosis, 7.6% (12/158) hepatocellular carcinoma, and 4.4% (7/158) underwent liver transplant #IDSky